Henoch Hong

Project leader for the public-private EU-funded IMMUcan consortium (IMI2); biomarker data scientist with focus on back-translation of clinical data for discovery research.

- Overseeing and coordinating all activities in the group Biomarkers and Immunoanalysis - Line manager for Scientists and Senior Scientists

- Development of strategies to facilitate the discovery of biomarker candidates accompanying clinical trials at CureVac - Establishing, validating and performing cellular assays to monitor the efficacy of immunotherapeutics and vaccines in clinical trials - Reviewing and contributing to clinical documents for biomarker content including statistical analysis plans, study synopses and subsequent reports - Presentation of data at scientific meetings and invited talks and preparing scientific papers

- Establishing, validating and performing cellular assays to monitor the efficacy of immunotherapeutics and vaccines in clinical trials - Reviewing and contributing to clinical documents for biomarker content including statistical analysis plans, study synopses and subsequent reports - Presentation of data at scientific meetings and invited talks and preparing scientific papers - Since August 2015: Line manager for 7 technical assistants

- Establishing virus suppression assays for CD8 T cells and NK cells - Highly parallel transcriptional analyses and identification of immunological correlates of vaccine protection - Supervision of summer students

- Innate immunity in chronic HIV infection with focus on NK cells and dendritic cells - Identification of NK cell correlates of delayed HIV disease progression - Supervision of medical students and junior PhD students

- Zellbiologie (Immunologie, Onkologie) - Molekularbiologie - Biochemie